Q: How does Everolimus work?

Everolimus, the active ingredient in Zortress, works by inhibiting the mammalian target of rapamycin (mTOR) pathway. This pathway plays a crucial role in cell proliferation, growth, and survival. By binding to the FKBP-12 protein, everolimus forms a complex that inhibits mTOR, thereby suppressing T-cell proliferation and cytokine production, which helps prevent organ rejection.

Question 1

What is Zortress used for?

Accepted Answer

Zortress is used to prevent organ rejection in patients who have undergone kidney or liver transplants. It works by suppressing the immune system's response to the transplanted organ, helping to ensure the body does not reject it. Zortress is typically used in combination with other immunosuppressants to manage the body's immune response effectively.

Question 2

How does Everolimus work?

Accepted Answer

Everolimus, the active ingredient in Zortress, is a mTOR inhibitor presented as a 0.75 mg tablet for oral use. It is used to prevent organ rejection in kidney or liver transplant recipients. GNH USA supplies Zortress as a licensed, GDP-compliant international pharmaceutical supplier serving transplant centres worldwide.

Zortress is a critical medication for patients who have undergone organ transplants, helping to ensure the body does not reject the new organ. It is part of a broader regimen that includes other immunosuppressants to manage the body's immune response.

Question 3

What is the usual dose of Zortress?

Accepted Answer

The usual dose of Zortress is determined by a healthcare professional based on the patient's specific needs and medical history. For kidney transplant patients, an initial dose of 0.75 mg orally twice daily is recommended in combination with reduced doses of cyclosporine. For liver transplant patients, an initial dose of 1 mg orally twice daily is recommended in combination with reduced doses of tacrolimus. Dose adjustments may be necessary based on blood concentrations and individual response.

Question 4

Is Zortress safe during pregnancy or breastfeeding?

Accepted Answer

Zortress should be avoided during pregnancy due to potential risks to the fetus. It is also not recommended during breastfeeding due to potential risks to the infant. Patients should discuss their reproductive health and contraceptive options with their healthcare provider before starting Zortress.

Question 5

How do I order Zortress from GNH USA?

Accepted Answer

To order Zortress from GNH USA, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then reply with pricing, availability, shipping, and the import paperwork.

Question 6

How does Zortress compare to other immunosuppressants?

Accepted Answer

Zortress is an mTOR inhibitor, which differs from other immunosuppressants like calcineurin inhibitors (e.g., tacrolimus) and corticosteroids. It is specifically used to prevent organ rejection in transplant patients and is often used in combination with other immunosuppressants. The choice of immunosuppressant depends on the patient's specific needs and medical history, as determined by a healthcare professional.

Question 7

How should Zortress be stored and handled?

Accepted Answer

Zortress should be stored below 25°C, keeping it in the original pack and protecting it from moisture. It is important to follow the storage instructions provided with the medication to ensure its effectiveness and safety. Patients should also handle the medication carefully and follow their healthcare provider's instructions for administration.

Question 8

How is Zortress administered?

Accepted Answer

Zortress is administered orally in the form of tablets. The dosage and administration schedule are determined by a healthcare professional based on the patient's specific needs and medical history. It is important to follow the prescribed dosage and administration instructions to ensure the medication's effectiveness and safety.

Question 9

What are the most serious risks to watch for with Zortress?

Accepted Answer

The most serious risks associated with Zortress include an increased risk of infections, wound healing problems, lung problems, kidney problems, and blood clots. Patients should be monitored regularly by their healthcare provider and report any unusual symptoms or side effects immediately. It is important to follow the healthcare provider's instructions for monitoring and managing these risks.

Question 10

Who should not use Zortress?

Accepted Answer

Zortress should not be used by patients who are allergic to everolimus or any of the other ingredients in the medication. It should also be avoided during pregnancy and breastfeeding due to potential risks to the fetus and infant. Patients with certain medical conditions, such as severe liver or kidney problems, may also need to avoid Zortress. It is important to discuss any medical conditions and allergies with a healthcare provider before starting Zortress.